Leading US Clinical Labs and Cancer Centers Adopt NanoString's Breast Cancer Assay

News   Dec 12, 2013

 
Leading US Clinical Labs and Cancer Centers Adopt NanoString's Breast Cancer Assay
 
 
 

RELATED ARTICLES

Detecting Heart Disease with an AI App

News

The process of assessing and monitoring heart disease, the leading cause of death in the US, is often expensive and time-consuming. A new app that incorporates pulse data to diagnose arterial changes could simplify the whole process.

READ MORE

A New, Streamlined Approach to Diagnosing and Treating Bowel Cancer

News

Researchers at the South Australian Health and Medical Research Institute (SAHMRI) and the University of Adelaide have discovered a faster, more cost-effective way to determine which DNA mutations cause human bowel cancer.

READ MORE

New Rapid-fire Method Using Pathology Images & Tumor Data May Help Guide Cancer Therapies

News

By combining data on pathology images of 13 types of cancer and correlating that with clinical and genomic data, researchers are able to identify tumor-infiltrating lymphocytes, which will enable cancer specialists to generate tumor-immune information from routinely gathered pathology slides.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE